Minimally Invasive Quad Tendon Harvesting System Delivers Superior Patient Outcomes - Greater Strength, Lower Failure Risk, Reduced Pain, Limited Scarring, Shorter Rehabilitation
Raleigh, North Carolina--(Newsfile Corp. - September 23, 2020) - QuadVantage Technologies, Inc. today announced that it has completed the development phase for its Quadriceps ACL Reconstruction System, a patented and clinically tested instrument set and procedure designed to transform ACL reconstruction outcomes by bringing the use of the Quadriceps tendon graft and corresponding superior patient benefits into the mainstream. The Company expects to make the specialized instrumentation and Quadriceps harvesting techniques commercially available during H1 2021, once it completes the final stage of biocompatibility, sterilization and packaging testing required by the FDA.
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- QuadVantage quadricep tendon harvesting system establishes new gold standard for ACL reconstruction by bringing use of Quadriceps tendon graft into the mainstream
- QuadVantage System is clinically shown to address key issues prevalent with existing ACL reconstruction methods resulting in greater strength, lower failure risk, reduced pain, limited scarring, and shorter rehabilitation
- Innovative, patented and clinically tested QuadVantage system is on track for H1 2021 commercial launch
Click image above to view full announcement.
Safe Harbor Statements
Results noted are based on third party studies as well as QuadVantage’s experience over the course of its clinical evaluation. Please see references included under the Clinical Results tab on the Company’s website.
All statements included in this press release other than statements of historical fact are forward-looking statements. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted.
Contacts:
Tom Gutierrez,
919-740-0093
Tom@quadvantageinc.com
Source: QuadVantage Technologies
Distributed by: Reportable, Inc.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/64462
